Total Payments
$19,805
2024 Payments
$2,298
Companies
46
Transactions
1,371
Medicare Patients
8,616
Medicare Billing
$603,415
Payment Breakdown by Category
Food & Beverage$19,756 (99.8%)
Education$48.87 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,756 | 1,365 | 99.8% |
| Education | $48.87 | 6 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,569 | 217 | $0 (2024) |
| PFIZER INC. | $2,040 | 134 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,914 | 105 | $0 (2024) |
| ABBVIE INC. | $1,557 | 120 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,275 | 99 | $0 (2024) |
| Lilly USA, LLC | $1,224 | 82 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,107 | 86 | $0 (2023) |
| Merck Sharp & Dohme LLC | $822.21 | 67 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $771.81 | 45 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $671.14 | 38 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,298 | 138 | ABBVIE INC. ($439.48) |
| 2023 | $2,941 | 181 | PFIZER INC. ($433.32) |
| 2022 | $2,650 | 169 | ABBVIE INC. ($363.02) |
| 2021 | $2,655 | 184 | Novo Nordisk Inc ($412.23) |
| 2020 | $1,934 | 136 | Novo Nordisk Inc ($351.44) |
| 2019 | $2,197 | 171 | Novo Nordisk Inc ($317.15) |
| 2018 | $2,372 | 182 | Novo Nordisk Inc ($408.20) |
| 2017 | $2,758 | 210 | SANOFI-AVENTIS U.S. LLC ($366.88) |
All Payment Transactions
1,371 individual payment records from CMS Open Payments — Page 1 of 55
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: Diabetes | ||||||
| 12/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $6.98 | General |
| Category: PAIN | ||||||
| 12/19/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: VACCINES | ||||||
| 12/10/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Oncology | ||||||
| 12/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: RESPIRATORY | ||||||
| 12/02/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Diabetes | ||||||
| 11/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: RESPIRATORY | ||||||
| 11/22/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: PAIN | ||||||
| 11/15/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: Respiratory | ||||||
| 11/15/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/11/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: VACCINES | ||||||
| 11/06/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/31/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: VACCINE | ||||||
| 10/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: PAIN | ||||||
| 10/18/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/17/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: Diabetes | ||||||
| 10/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: RESPIRATORY | ||||||
| 10/08/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.04 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,736 | 3,910 | $259,298 | $140,060 |
| 2022 | 28 | 2,073 | 4,385 | $286,761 | $149,095 |
| 2021 | 34 | 2,401 | 4,709 | $316,209 | $156,470 |
| 2020 | 32 | 2,406 | 5,038 | $360,194 | $157,790 |
Total Patients
8,616
Total Services
18,042
Medicare Billing
$603,415
Procedure Codes
118
All Medicare Procedures & Services
118 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 302 | 943 | $150,880 | $72,239 | 47.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 51 | 51 | $16,320 | $14,091 | 86.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 154 | 220 | $26,400 | $11,351 | 43.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 87 | 87 | $14,355 | $10,501 | 73.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 300 | 811 | $9,732 | $6,640 | 68.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 129 | 130 | $4,550 | $3,677 | 80.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 141 | 348 | $5,220 | $3,232 | 61.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 24 | $5,280 | $2,823 | 53.5% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 70 | 71 | $2,840 | $2,374 | 83.6% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 15 | 15 | $3,450 | $2,326 | 67.4% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 45 | 51 | $2,805 | $1,992 | 71.0% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 59 | 59 | $2,242 | $1,840 | 82.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 77 | 167 | $5,010 | $1,480 | 29.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 48 | 48 | $1,680 | $1,368 | 81.4% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 13 | 51 | $2,295 | $1,230 | 53.6% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 21 | 25 | $2,125 | $966.50 | 45.5% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 25 | 31 | $1,385 | $720.42 | 52.0% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 18 | 40 | $960.00 | $591.54 | 61.6% |
| 73502 | X-ray of hip, 2-3 views | Office | 2023 | 11 | 12 | $700.00 | $339.50 | 48.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 33 | 38 | $152.00 | $83.60 | 55.0% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 11 | 11 | $88.00 | $67.21 | 76.4% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 43 | 192 | $344.00 | $64.71 | 18.8% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 16 | 81 | $81.00 | $33.51 | 41.4% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 47 | 404 | $404.00 | $30.11 | 7.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 327 | 905 | $146,105 | $69,356 | 47.5% |
About Dr. Scott Kemp, D.O
Dr. Scott Kemp, D.O is a Family Medicine healthcare provider based in Northport, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2010. The National Provider Identifier (NPI) number assigned to this provider is 1982925517.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Kemp, D.O has received a total of $19,805 in payments from pharmaceutical and medical device companies, with $2,298 received in 2024. These payments were reported across 1,371 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($19,756).
As a Medicare-enrolled provider, Kemp has provided services to 8,616 Medicare beneficiaries, totaling 18,042 services with total Medicare billing of $603,415. Data is available for 4 years (2020–2023), covering 118 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Northport, AL
- Active Since 06/17/2010
- Last Updated 02/18/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1982925517
Products in Payments
- Ozempic (Drug) $1,329
- FARXIGA (Drug) $1,319
- TRELEGY ELLIPTA (Drug) $1,134
- ELIQUIS (Drug) $1,004
- XARELTO (Drug) $941.21
- VRAYLAR (Drug) $855.06
- JARDIANCE (Drug) $708.22
- TOUJEO (Drug) $506.45
- XIFAXAN (Drug) $475.50
- UBRELVY (Drug) $472.24
- MOUNJARO (Drug) $467.32
- NURTEC ODT (Drug) $448.11
- Victoza (Drug) $414.28
- INJECTAFER (Drug) $404.14
- TRULICITY (Drug) $349.62
- Rybelsus (Drug) $333.08
- JANUVIA (Drug) $331.58
- TRINTELLIX (Drug) $311.14
- Azstarys (Drug) $298.06
- Vascepa (Drug) $288.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Northport
Clinton Mcentyre, M.d, M.D
Family Medicine — Payments: $20,557
Family Medicine $20,557
Dr. Malika Aryanpure, M.d, M.D
Family Medicine — Payments: $10,105
Family Medicine $10,105
Dr. Caroline Day, Md, MD
Family Medicine — Payments: $10,016
Family Medicine $10,016
Ronald Harrison, Do, DO
Family Medicine — Payments: $7,099
Family Medicine $7,099
Steven Coppock, M.d, M.D
Family Medicine — Payments: $6,510
Family Medicine $6,510
Dr. Edwin Christensen, M.d, M.D
Family Medicine — Payments: $5,185
Family Medicine $5,185